FRIDAY, Jan. 28, 2022 (HealthDay News) — COVID-19 vaccines activate long-lasting immune system T-cells that target coronavirus variants of concern, including Delta and Omicron, new research shows. The research team at the La Jolla Institute for Immunology in California studied adults who were fully vaccinated with the Pfizer, Moderna, JohnsonContinue Reading

FRIDAY, Jan. 28, 2022 (HealthDay News) — Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson’s disease, new research shows. Some previous studies have found that people with rheumatoid arthritis have a lower risk of Parkinson’s, and it was suggested that a class of rheumatoid arthritis drugsContinue Reading

A new strategy to fight deadly liver cancers. Surgical removal of tumors on the liver doesn’t guarantee they won’t return. But a new approach — starting patients on immunotherapy before surgery — may greatly improve survival, doctors say. Read more Physical therapy or steroid injections — what’s best for arthriticContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — In response to claims that a man was denied a heart transplant because he refused to get vaccinated against COVID-19, Brigham and Women’s Hospital in Boston said Wednesday that its transplant policies mirror those used across the United States. In a crowdfunding appealContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — An initial surge in antibody levels against the Omicron variant after a booster dose of the Moderna COVID vaccine wanes within six months, but the antibodies remained effective against it in lab tests, a new study finds. Researchers analyzed antibody levels in volunteersContinue Reading

THURSDAY, Jan. 27, 2022 (American Heart Association News) — Dr. Jeremiah Stamler, a trailblazing cardiologist who helped people understand the critical connection between healthy lifestyle and heart health – and who continued his passionate work well beyond his 100th birthday – died early Wednesday. Stamler, known as “the father ofContinue Reading